- Home
- CNC vs NUWE Comparison
CNC vs NUWE Comparison
Compare CNC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNC
- NUWE
- Stock Information
- Founded
- CNC 1984
- NUWE 1999
- Country
- CNC United States
- NUWE United States
- Employees
- CNC N/A
- NUWE N/A
- Industry
- CNC Medical Specialities
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNC Health Care
- NUWE Health Care
- Exchange
- CNC Nasdaq
- NUWE Nasdaq
- Market Cap
- CNC 14.3B
- NUWE 2.9M
- IPO Year
- CNC 2001
- NUWE N/A
- Fundamental
- Price
- CNC $35.02
- NUWE $3.80
- Analyst Decision
- CNC Hold
- NUWE
- Analyst Count
- CNC 17
- NUWE 0
- Target Price
- CNC $38.44
- NUWE N/A
- AVG Volume (30 Days)
- CNC 11.2M
- NUWE 124.0K
- Earning Date
- CNC 10-29-2025
- NUWE 11-12-2025
- Dividend Yield
- CNC N/A
- NUWE N/A
- EPS Growth
- CNC N/A
- NUWE N/A
- EPS
- CNC N/A
- NUWE N/A
- Revenue
- CNC $167,680,000,000.00
- NUWE $8,318,000.00
- Revenue This Year
- CNC $30.96
- NUWE $6.53
- Revenue Next Year
- CNC N/A
- NUWE $51.63
- P/E Ratio
- CNC N/A
- NUWE N/A
- Revenue Growth
- CNC 14.57
- NUWE N/A
- 52 Week Low
- CNC $25.08
- NUWE $2.93
- 52 Week High
- CNC $66.81
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- CNC 50.49
- NUWE 56.22
- Support Level
- CNC $32.87
- NUWE $3.01
- Resistance Level
- CNC $37.57
- NUWE $3.32
- Average True Range (ATR)
- CNC 1.30
- NUWE 0.21
- MACD
- CNC -0.29
- NUWE 0.07
- Stochastic Oscillator
- CNC 45.80
- NUWE 81.31
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.